The NPR Short Wave podcast discusses a study led by Boris Heifets at Stanford University, who aims to investigate the potential therapeutic effects of ketamine without the psychedelic experience. By putting patients to sleep, Heifets seeks to isolate the drug's effects on the brain, making it easier to evaluate its benefits without the confounding factor of known psychedelic experiences. This research could pave the way for more effective therapeutic applications of psychedelics, expanding their potential uses in medicine.
Patients generally know if they received a psychedelic drug or not, complicating the separation of subjective experiences from potential therapeutic benefits.
Boris Heifets, a Stanford anesthesiologist and neuroscientist, explores administering ketamine while patients are asleep to isolate its neurological effects.
Collection
[
|
...
]